It's an eye-catching angle in the story of an experimental treatment for Ebola: The drug comes from tobacco plants that were turned into living pharmaceutical factories.
Biotechnology
Aug 15, 2014
1
0
Getting life-saving vaccines to the most remote parts of the world is no easy feat. Biopharmaceuticals are highly sensitive to heat and cold and can perish if their temperature shifts a few degrees.
Engineering
Mar 25, 2014
0
0
You'd be forgiven for thinking science is under attack. Climate science has been challenged by deniers and sceptics, vaccination rates are falling thanks to anti-vaccination movements, and GM crops are pillaged by anti-GM ...
Social Sciences
Oct 3, 2013
84
2
(Phys.org) —Researchers are racing the clock to better understand a deadly virus which has the potential to intensify population declines in the endangered Asian elephant.
Ecology
Jun 17, 2013
0
0
(Phys.org)—A dramatic image of a virus replicating and spreading through cells, destroying them as it goes, has been captured by University of Sydney researchers.
Cell & Microbiology
Nov 1, 2012
0
0
Salmonella Typhi (S. Typhi) is the causative agent of typhoid fever, a serious health threat resulting in some 22 million new cases yearly and approximately 217,000 fatalities. A number of novel vaccine candidates using live ...
Cell & Microbiology
Jun 28, 2012
0
0
Worries over vaccine risks can allow preventable contagious diseases, such as measles and whooping cough, to make a comeback. A new study, published in PLoS Computational Biology, shows how to predict ways in which population ...
Mathematics
Apr 5, 2012
0
0
Developing a drug or vaccine requires a delicate balancing act with the immune system. On one hand, medications need to escape detection by the immune system in order to perform their function. But vaccinations — de-activated ...
Biochemistry
Mar 26, 2012
1
0
One only has to be reminded of the BSE crisis and the MMR vaccine scare to recognise the importance of having policy informed by the best available science. Now, a collaboration of over fifty academics and policy makers from ...
Other
Mar 10, 2012
0
0
HIV has eluded vaccine-makers for thirty years, in part due to the virus' extreme ability to mutate. Physical scientists and clinical virologists from the Massachusetts Institute of Technology (MIT) and the Ragon Institute ...
Biochemistry
Feb 23, 2012
0
0
